Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
This study has been completed.
Study NCT00135720   Information provided by Massachusetts General Hospital
First Received: August 24, 2005   Last Updated: May 19, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pemphigus Vulgaris
Additional conditions recognized in this trial
Pemphigus
More general conditions related to this trial
Autoimmune Diseases
Immune System Diseases
Skin Diseases
Skin Diseases, Vesiculobullous
Interventions listed in this trial
Enbrel (Etanercept)
Additional drug interventions recognized in this trial
TNFR-Fc fusion protein
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Massachusetts General Hospital
Brigham and Women's Hospital
Stanford University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services